Cautious optimism as North America continues lagging

07/08/25 -"Avolta’s H1 performance aligned with analysts’ expectations. While North America remained broadly flat due to softer US traffic and a slowdown in F&B, other regions maintained solid ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

07/08/25

Download

You may also be interested by these reports :

07/08/25

Galenica

Galenica turned in a good H1 2025 performance, with sales climbing 5% to CHF 1,995.4 million, outpacing the Swiss pharma market’s 4.8% growth. ...

07/08/25

Avolta

Avolta’s H1 performance aligned with analysts’ expectations. While North America remained broadly flat due to softer US traffic and a slowdown in ...

06/08/25

Marks & Spencer

The sharp earnings erosion in the short term has weighed on our peer-based valuation. Nevertheless, we remain positive as the reshaping strategy is ...

06/08/25

Zalando

2Q25 results met expectation – Specified FY25E guidance (incl. AY)

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue